Cargando…

Multivalent Human Papillomavirus L1 DNA Vaccination Utilizing Electroporation

OBJECTIVES: Naked DNA vaccines can be manufactured simply and are stable at ambient temperature, but require improved delivery technologies to boost immunogenicity. Here we explore in vivo electroporation for multivalent codon-optimized human papillomavirus (HPV) L1 and L2 DNA vaccination. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwak, Kihyuck, Jiang, Rosie, Jagu, Subhashini, Wang, Joshua W., Wang, Chenguang, Christensen, Neil D., Roden, Richard B. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607584/ https://www.ncbi.nlm.nih.gov/pubmed/23536912 http://dx.doi.org/10.1371/journal.pone.0060507

Ejemplares similares

Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types
por: Kwak, Kihyuck, et al.
Publicado: (2014)

Optimization of Multimeric Human Papillomavirus L2 Vaccines
por: Jagu, Subhashini, et al.
Publicado: (2013)

Capsomer Vaccines Protect Mice from Vaginal Challenge with Human Papillomavirus
por: Wu, Wai-Hong, et al.
Publicado: (2011)

Role of L2 cysteines in papillomavirus infection and neutralization
por: Gambhira, Ratish, et al.
Publicado: (2009)

Measurement of Neutralizing Serum Antibodies of Patients Vaccinated with Human Papillomavirus L1 or L2-Based Immunogens Using Furin-Cleaved HPV Pseudovirions
por: Wang, Joshua W., et al.
Publicado: (2014)

Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines
por: Jagu, Subhashini, et al.
Publicado: (2009)

Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes
por: Kalnin, Kirill, et al.
Publicado: (2017)

Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
por: Schellenbacher, Christina, et al.
Publicado: (2013)

Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection
por: Jiang, Rosie T., et al.
Publicado: (2017)

Electroporation-Mediated DNA Vaccination
por: Fagone, Paolo, et al.
Publicado: (2010)

Multivalent Fusion DNA Vaccine against Brucella abortus
por: Gómez, Leonardo, et al.
Publicado: (2017)

Immunologic Control of Mus musculus Papillomavirus Type 1
por: Wang, Joshua W., et al.
Publicado: (2015)

Efficient Delivery of DNA Vaccines using Human Papillomavirus Pseudovirions
por: Peng, Shiwen, et al.
Publicado: (2010)

Increased B Cell Understanding Puts Improved Vaccine Platforms Just Over the Horizon
por: Notario, Geneva Rose, et al.
Publicado: (2022)

Utility of Multivalent Aptamers to Develop Nanoscale DNA Devices against Surface Receptors
por: Freage, Lina, et al.
Publicado: (2021)

Designer tetrahedral DNA framework-based microfluidic technology for multivalent capture and release of circulating tumor cells
por: Wang, Chenguang, et al.
Publicado: (2022)

DNA-scaffolded multivalent vaccine against SARS-CoV-2
por: Chen, Fangfang, et al.
Publicado: (2023)

Optimised electroporation mediated DNA vaccination for treatment of prostate cancer
por: Ahmad, Sarfraz, et al.
Publicado: (2010)

Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated Diseases
por: Olczak, Pola, et al.
Publicado: (2020)

Immunohistochemical detection of Human Papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: Potential utility in diagnosis and management
por: Yemelyanova, A, et al.
Publicado: (2012)

Adipose tissue: a new target for electroporation-enhanced DNA vaccines
por: Fisher, P D, et al.
Publicado: (2017)

Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants
por: Flingai, Seleeke, et al.
Publicado: (2013)

Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination
por: Yang, Benjamin, et al.
Publicado: (2015)

Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody
por: Peng, Shiwen, et al.
Publicado: (2021)

Using Multivalent Adenoviral Vectors for HIV Vaccination
por: Gu, Linlin, et al.
Publicado: (2013)

Chitosan-DNA nanoparticles enhanced the immunogenicity of multivalent DNA vaccination on mice against Trueperella pyogenes infection
por: Huang, Ting, et al.
Publicado: (2018)

Protection of chickens against infectious bronchitis virus with a multivalent DNA vaccine and boosting with an inactivated vaccine
por: Yan, Fang, et al.
Publicado: (2013)

Intradermal DNA vaccine delivery using vacuum-controlled, needle-free electroporation
por: Generotti, Alison, et al.
Publicado: (2023)

Modulation of Vaccine-Induced HIV-1-Specific Immune Responses by Co-Electroporation of PD-L1 Encoding DNA
por: Tannig, Pierre, et al.
Publicado: (2020)

Whole-genome detection using multivalent DNA-coated colloids
por: Xu, Peicheng, et al.
Publicado: (2023)

Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
por: Peng, Shiwen, et al.
Publicado: (2016)

Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)
por: Huber, Bettina, et al.
Publicado: (2017)

A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever
por: Cashman, Kathleen A., et al.
Publicado: (2017)

Multivalent counterions induced attraction between DNA polyelectrolytes
por: Chen, Xu, et al.
Publicado: (2020)

‘Multicopy Multivalent’ Glycopolymer-Stabilized Gold Nanoparticles as Potential Synthetic Cancer Vaccines
por: Parry, Alison L., et al.
Publicado: (2013)

Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine
por: Lingel, Amy, et al.
Publicado: (2017)

In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers
por: Vasan, Sandhya, et al.
Publicado: (2011)

DNA vaccination by intradermal electroporation induces long-lasting immune responses in rhesus macaques
por: Kulkarni, Viraj, et al.
Publicado: (2014)

Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma
por: Yuan, Jianda, et al.
Publicado: (2013)

Simultaneous electroporation and dielectrophoresis in non-electrolytic micro/nano-electroporation
por: Lyu, Chenang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4rtqaon0mohkj1gv4ro6ad6emv